Research

Mixed

Metabolic surgery reduces long-term cardiovascular mortality and microvascular complications in patients with Type 2 Diabetes compared to medical management.

For patients with Type 2 Diabetes and obesity, metabolic surgery not only improves blood sugar but also significantly reduces the risk of heart disease death and kidney/eye complications over the long term compared to standard medical care.

GoodSupportsMEDIUM confidence
The SOS study has the longest outcome follow-up (median of 14.7 years). CVD mortality in the surgical group was lower than in control subjects (adjusted hazard ratio 0.47 [95% CI 0.29–0.76]; P = 0.002)... surgery was associated with a 50% reduction in microvascular complications
Philip R. Schauer et al. · Diabetes Care · 2016

Why this rating

Based on observational cohort studies (SOS, matched cohorts), not RCTs (which were underpowered for these endpoints).

Source

Clinical Outcomes of Metabolic Surgery: Efficacy of Glycemic Control, Weight Loss, and Remission of Diabetes

Philip R. Schauer et al. · Diabetes Care · 2016

DOI 10.2337/dc16-0382

narrative_reviewCited 208×
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →